州主导的医疗服务提供体系与支付改革对人群水平糖尿病检测和管理的影响
该研究评估2013至2017年州创新模型(SIM)实施是否与已诊断糖尿病患病率、住院率或30天再入院率相关。准实验设计比较12个SIM州与5个对照州,采用双重差分回归分析17个州889个县21,055,714例糖尿病成人住院,再入院分析另用9州11,812,993例住院的比较中断时间序列。结果显示SIM州与对照州已诊断糖尿病患病率变化无显著差异,住院率估计不一致,SIM州30天再入院 odds 增加更多。
要点
- SIM州与对照州已诊断糖尿病患病率变化无显著差异。
- 住院率双重差分估计不一致:分别为-5.34至-0.37和-13.16至0.92。
- SIM州30天再入院 odds 增加更多:第一轮AOR 1.07(95%CI 1.04,1.11;P<0.001),第二轮AOR 1.06(95%CI 1.03,1.10;P=0.001)。
核心结论
- SIM倡议聚焦不足,未对糖尿病检测或管理产生人群水平效应。
- SIM州糖尿病成人30天再入院增加幅度大于对照州,提示参与州主导医疗服务提供体系与支付改革所需的多支付方协调努力可能存在非预期效应。
研究设计与样本
- 准实验设计,比较2013至2017年SIM实施前后12个SIM州与5个对照州的研究结局。
- 使用双重差分回归模型分析2010至2017年17个州889个县21,055,714例年龄≥18岁已诊断糖尿病成人住院。
- 再入院分析使用比较中断时间序列模型,纳入9个州子集的11,812,993例住院。
主要发现
- SIM州与对照州已诊断糖尿病患病率变化无显著差异。
- 住院率在模型间不一致,双重差分估计分别为-5.34至-0.37和-13.16至0.92。
- 比较中断时间序列结果显示,SIM实施期间SIM州30天再入院 odds 增加大于对照州:第一轮AOR 1.07(95%CI 1.04,1.11;P<0.001),第二轮AOR 1.06(95%CI 1.03,1.10;P=0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The Centers for Medicare and Medicaid Services State Innovation Models (SIM) initiative has invested more than $1 billion to test state-led delivery system and payment reforms that can affect diabetes care management. We examined whether SIM implementation between 2013 and 2017 was associated with diagnosed diabetes prevalence or with hospitalization or 30-day readmission rate among diagnosed adults. RESEARCH DESIGN AND METHODS: The quasiexperimental design compared study outcomes before and after the SIM initiative in 12 SIM states versus five comparison states using difference-in-differences (DiD) regression models of 21,055,714 hospitalizations for adults age ≥18 years diagnosed with diabetes in 889 counties from 2010 to 2017 across the 17 states. For readmission analyses, comparative interrupted time series (CITS) models included 11,812,993 hospitalizations from a subset of nine states. RESULTS: Diagnosed diabetes prevalence changes were not significantly different between SIM states and comparison states. Hospitalization rates were inconsistent across models, with DiD estimates ranging from -5.34 to -0.37 and from -13.16 to 0.92, respectively. CITS results indicate that SIM states had greater increases in odds of 30-day readmission during SIM implementation compared with comparison states (round 1: adjusted odds ratio [AOR] 1.07; 95% CI 1.04, 1.11; P < 0.001; round 2: AOR 1.06; 95% CI 1.03, 1.10; P = 0.001). CONCLUSIONS: The SIM initiative was not sufficiently focused to have a population-level effect on diabetes detection or management. SIM states had greater increases in 30-day readmission for adults with diabetes than comparison states, highlighting potential unintended effects of engaging in the multipayer alignment efforts required of state-led delivery system and payment reforms.
引用
- Rodriguez HP, Fulton BD, Phillips AZ, et al. Effect of State-Led Delivery System and Payment Reforms on Population-Level Detection and Management of Diabetes. Diabetes Care. 2022. PMID: 35972261. doi:10.2337/dc21-2425
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。